← DSP Mutual Fund

DSP Healthcare Fund - Direct Plan - Growth

Equity Data as of Apr 2026 Comparing Mar 2026 → Apr 2026
Share: WhatsApp X
Stocks Held
25
Apr 2026
Equity Holdings
₹2,502.53 Cr
Equity only, excl. debt & cash
Top 5 Weight
37.2%
Moderate
Top 10 Weight
58.7%
Moderate
Changes
24
0 new · 0 exits
Top Sector
Pharmaceuticals & Biotechnology
65.1% of portfolio
📋 What Happened This Month Among existing holdings, Cohance Lifesciences Limited saw the biggest increase — now at 4.83% of the portfolio. IPCA Laboratories Limited was trimmed the most, now at 8.26%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 65.1%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Feb 2026 Mar 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 65.0% 65.2% +0.3%
Healthcare Services 12.6% 12.2% -0.4%
Insurance 1.5% 1.4% -0.1%
Retailing 0.5% 0.6% +0.0%
Healthcare Equipment & Supplies 0.2% 0.2% 0.0%
Mar 2026 Apr 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 65.2% 65.1% -0.2%
Healthcare Services 12.2% 12.5% +0.3%
Insurance 1.4% 1.4% -0.1%
Retailing 0.6% 0.5% 0.0%
Healthcare Equipment & Supplies 0.2% 0.2% +0.0%
Biggest Add
Cohance Lifesciences Limited
+1.73% · now 4.83%
Biggest Trim
IPCA Laboratories Limited
-1.13% · now 8.26%

What Changed?

Comparing Mar 2026 → Apr 2026

Mar 2026 Apr 2026
↑ 11 Increased ↓ 13 Decreased
#StockSectorMar 2026Apr 2026Change
1
Cohance Lifesciences Limited
₹151.77 Cr
Pharmaceuticals & Biotechnology 3.10% 4.83% +1.73%
2
Vijaya Diagnostic Centre Limited
₹105.68 Cr
Healthcare Services 2.79% 3.36% +0.57%
3
Indoco Remedies Ltd
₹67.74 Cr
Pharmaceuticals & Biotechnology 1.83% 2.16% +0.33%
4
Unichem Laboratories Ltd.
₹33.24 Cr
Pharmaceuticals & Biotechnology 0.86% 1.06% +0.20%
5
Alembic Pharmaceuticals Limited
₹107.83 Cr
Pharmaceuticals & Biotechnology 3.28% 3.43% +0.15%
6
Laurus Labs Limited
₹201.76 Cr
Pharmaceuticals & Biotechnology 6.29% 6.42% +0.13%
7
Kovai Medical Center and Hospital Limited
₹93.44 Cr
Healthcare Services 2.87% 2.97% +0.10%
8
Sai Life Sciences Limited
₹191.67 Cr
Pharmaceuticals & Biotechnology 6.02% 6.10% +0.08%
9
Aarti Drugs Ltd
₹32.07 Cr
Pharmaceuticals & Biotechnology 0.94% 1.02% +0.08%
10
Concord Biotech Limited
₹56.72 Cr
Pharmaceuticals & Biotechnology 1.75% 1.81% +0.06%
#StockSectorMar 2026Apr 2026Change
1
IPCA Laboratories Limited
₹259.70 Cr
Pharmaceuticals & Biotechnology 9.39% 8.26% -1.13%
2
Sun Pharmaceutical Industries Limited
₹277.68 Cr
Pharmaceuticals & Biotechnology 9.33% 8.84% -0.49%
3
Corona Remedies Limited
₹4.72 Cr
Pharmaceuticals & Biotechnology 0.63% 0.15% -0.48%
4
Gland Pharma Limited
₹161.19 Cr
Pharmaceuticals & Biotechnology 5.40% 5.13% -0.27%
5
Apollo Hospitals Enterprise Limited
₹148.73 Cr
Healthcare Services 5.00% 4.73% -0.27%
6
Pfizer Limited
₹94.52 Cr
Pharmaceuticals & Biotechnology 3.28% 3.01% -0.27%
7
Emcure Pharmaceuticals Limited
₹63.29 Cr
Pharmaceuticals & Biotechnology 2.14% 2.01% -0.13%
8
Cipla Limited
₹237.49 Cr
Pharmaceuticals & Biotechnology 7.68% 7.56% -0.12%
9
ICICI Lombard General Insurance Company Limited
₹42.57 Cr
Insurance 1.43% 1.35% -0.08%
10
Jupiter Life Line Hospitals Ltd
₹11.54 Cr
Healthcare Services 0.42% 0.37% -0.05%

Full Portfolio

25 stocks — Apr 2026

# Stock Sector Cap Weight & Value
1
₹277.68 Cr
Pharmaceuticals & Biotechnology
8.84%
2
₹259.70 Cr
Pharmaceuticals & Biotechnology
8.26%
3
₹237.49 Cr
Pharmaceuticals & Biotechnology
7.56%
4
₹201.76 Cr
Pharmaceuticals & Biotechnology
6.42%
5
₹191.67 Cr
Pharmaceuticals & Biotechnology
6.10%
6
₹161.19 Cr
Pharmaceuticals & Biotechnology
5.13%
7
₹151.77 Cr
Pharmaceuticals & Biotechnology
4.83%
8
₹148.73 Cr
Healthcare Services
4.73%
9
₹107.83 Cr
Pharmaceuticals & Biotechnology
3.43%
10
₹105.68 Cr
Healthcare Services
3.36%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
🏦 DSP Mutual Fund — Portfolio & Holdings
See all funds managed by DSP Mutual Fund — conviction stocks, monthly entries & exits

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.